Session RED |
|
Integration of Chemical Information |
|
Accelerating problem solving and decision making in medicinal chemistry through visualisationPaul Hawkins , OpenEye Scientific |
P‑01 |
Nanomaterial safety data integration with substance data model and federated searchNina Jeliazkova , Ideaconsult Ltd. |
P‑03 |
Can we agree on the structure represented by a SMILES string? A benchmark datasetNoel M O'Boyle , NextMove Software |
P‑05 |
Structure-Activity and Structure-Property Prediction |
|
Computational Studies of Integrin InhibitorsSaleh Saeed Alarfaji, The University of Nottingham |
P‑07 |
Fast prediction of the specific conductivity of electrolytes from the molecular structure of the solventRémi Bouteloup , CEA |
P‑09 |
Identification of novel sodium-dependent glucose co-transporter 1 inhibitors using proteochemometricsLindsey Burggraaff , Leiden University |
P‑11 |
Application of 3D-QSAR Methods in Drug Design & Discovery: Two Case StudiesGiulia Chemi , University of Siena |
P‑13 |
Applications of in silico approaches to decipher the structure and functions of ADAMTS13: En route to novel therapeutics of TTPBogac Ercig, Maastricht University |
P‑15 |
Confidence estimation of ADME properties using conformal predictionChristina Maria Founti, The University of Sheffield |
P‑17 |
Selectivity profiles in Activity AtlasMark Mackey, Cresset |
P‑19 |
KnowTox: Risk Assessment by Automated Read-Across and Machine LearningAndrea Morger, Charite Berlin |
P‑21 |
Machine learning to predict the recruitment profile of intracellular binding partners of G protein-coupled receptorsTrung Ngoc Nguyen, Freie Universität Berlin |
P‑23 |
Estimation of electrophilicity for warheads of covalent protease inhibitorsSzymon Pach, Freie Universität Berlin |
P‑25 |
A web-based informatics platform for PhysChem/ADME/Tox property predictionsAndrius Sazonovas, ACD/Labs, Inc. |
P‑27 |
Development of a novel structure descriptor combining molecular shape and surface propertiesAnke Schultz, Technische Universität Braunschweig |
P‑29 |
Classification of corneal permeability of drug-like compounds using data mining and machine learningCarlos J. V. Simões , BSIM Therapeutics |
P‑31 |
Coarse-grained approaches for prediction of solubility and membrane permeability of large drugs: The Why and the HowTeun Sweere, Culgi BV and Leiden University |
P‑33 |
Molecular Dynamics Fingerprints (MDFP): Combining MD and Machine Learning to Predict Physicochemical PropertiesShuzhe Wang , ETHZ |
P‑35 |
Structure-Based Drug Design and Virtual Screening |
|
Towards Small Molecule Inhibition of HSP90 DimerizationDavid Bickel, Heinrich Heine University Duesseldorf |
P‑37 |
Reverse Virtual Screening Procedure for Identifying the Target of an Antiplasmodial Hit CompoundSimone Brogi , University of Siena |
P‑39 |
Conformational Sampling and Binding Affinity Prediction of MacrocyclesDaniel Cappel , Schrödinger GmbH |
P‑41 |
Using FEP (Free Energy Perturbation) Calculations to estimate relative binding affinities and selectivity for GPCR targetsFrancesca Deflorian, Heptares Therapeutics Ltd |
P‑43 |
Can I Have Seconds?Christiane Ehrt, TU Dortmund University |
P‑45 |
Virtual Screening of CCR5 Inhibitors as Potential Anti- Colorectal Cancer AgentsMariam El-Zohairy, Faculty of Pharmacy and Biotechnology at the German University in Cairo |
P‑47 |
SILCS reproduces experimental binding trends for 31 TrmD ligandsOlgun Guvench, SilcsBio |
P‑49 |
Fuzzy ligands for allosteric target detection and lead identificationSusanne Hermans, Heinrich-Heine University, Düsseldorf |
P‑51 |
A fast and efficient rescoring method based on binding information of fragment and drug-like ligandsCélien Jacquemard, Université de Strasbourg |
P‑53 |
Mapping Binding Site Thermodynamics by 3D RISM Theory for Drug DesignJulia Beatrice Jasper, TU Dortmund |
P‑55 |
Structure based design of potent and selective ligands for the adenosine receptor familyWillem Jespers , Uppsala University/Leiden University |
P‑57 |
Transferable Neural Networks Architecture for Low Data Drug DiscoveryMun-Hwan Lee, Seoul University |
P‑59 |
Tetris of HDAC Inhibitor DesignJelena Melesina, Martin Luther University Halle-Wittenberg |
P‑61 |
Applications of Binding Free Energy Calculations and QSAR Modeling to Design Novel Inhibitors for Human Myt1 KinaseAbdulkarim Najjar , Martin Luther University of Halle-Wittenberg |
P‑63 |
Estimation of solvation free energies by continuum methods: How to tackle halogenated species?Rafael Nunes , Centro de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa |
P‑65 |
A multi-target approach to neurodegenerative diseases Sebastian Oddsson, University of Iceland |
P‑67 |
A Computational Platform For Fragment EvolutionSerena Gaetana Piticchio, University of Barcelona |
P‑69 |
NAOMInext - Reaction-Driven Probing of Protein Binding SitesKai Sommer , University of Hamburg |
P‑71 |
Effects of MD-MM/GBSA Parameters on the Rank-Ordering of Ligands in Drug DesignNikolaus Stiefl, Novartis Institute of Biomedical Research |
P‑73 |
Can I make this into a macrocycle? Effective methods for fragment growing, joining and cyclisation.Paolo Tosco, Cresset |
P‑75 |
Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular SurfacesAndrea Volkamer, Charité – Universitätsmedizin Berlin |
P‑77 |
Session BLUE |
|
Analysis of Large Chemical Data Sets |
|
Characterization of the Chemical Space of Known and of Readily Purchasable Natural ProductsYa Chen, University of Hamburg |
P‑02 |
Effects of missing data on multitask prediction performanceAntonio de la Vega de Leon , University of Sheffield |
P‑04 |
Compound enumeration using Reaction WorkflowsJameed Hussain, Dotmatics |
P‑06 |
chem2vec : vector embedding of atoms and moleculesNina Jeliazkova , Ideaconsult Ltd. |
P‑08 |
Building and searching large chemistry spacesUta Lessel, Boehringer Ingelheim Pharma GmbH & Co. KG |
P‑10 |
Learning from Extant Medicinal Chemistry to Accelerate Hit Identification and Optimisation in Drug DiscoveryYi Mok, The Institute of Cancer Research |
P‑12 |
HTS workup at AZ – state of the artWillem Nissink , AstraZeneca |
P‑14 |
A Comprehensive Evaluation of ACD/LogD on a Pharmaceutical Compound SetAndrius Sazonovas, ACD/Labs, Inc. |
P‑16 |
Halogens in protein-ligand binding mechanism: a structural perspectiveNicolas Ken Shinada, Discngine |
P‑18 |
Interoperable and scalable data analysis in metabolomicsChristoph Steinbeck, Friedrich-Schiller-University |
P‑20 |
Supporting the assessment of the purging potential mutagenic impurities via analysis of patent literatureSamuel Webb, Lhasa Limited |
P‑22 |
Dealing with Biological Complexity |
|
Metabolite Structure Prediction Benefits from Cytochrome P450 Regioselectivity PredictionChristina de Bruyn Kops , Universität Hamburg |
P‑24 |
Small Molecule Binding Site Prediction - Know Your NeedsChristiane Ehrt, TU Dortmund University |
P‑26 |
Molecular nature of the increased activity of the Uridine 5’-diphospho-glucuronosyltransferase nine-fold mutant 1A5*8David Machalz , Freie Universität Berlin |
P‑28 |
Searching within HELMAnne Mund, quattro research GmbH |
P‑30 |
HELM-driven Integration of Peptides into Structure-Based Drug Design and CheminformaticsConor Scully, Heptares Therapeutics |
P‑32 |
Cheminformatics |
|
Machine Learning Models of Hydrogen Bond Basicity Based on Anisotropy Atomic Reactivity DescriptorsChristoph Bauer, ETH Zürich |
P‑34 |
International Chemical Identifier for Reactions (RInChI)Gerd Blanke, StructurePendium Technologies GmbH |
P‑36 |
Characterizing Somatic Cancer Mutations in GPCRsBrandon Jeremy Bongers , Leiden University |
P‑38 |
A Novel Approach to Assign Absolute Configuration Using Vibrational Circular DichroismLennard Böselt, ETHZ |
P‑40 |
A Novel Search Engine and Application for Very Large Chemistry Database MiningRobert D Brown, Dotmatics |
P‑42 |
Designing of a drug-like natural compound library for secondary metabolites collected from the African flora.Veranso Conrad Simoben , Martin-Luther-University, Halle-Wittenberg |
P‑44 |
mmpdb: A Matched Molecular Pair Platform for Large Multi-Property DatasetsAndrew Dalke, Dalke Scientific Software |
P‑46 |
3D-e-Chem: Structural Cheminformatics Workflows for Computer-Aided Drug DiscoveryChris de Graaf , Heptares Therapeutics |
P‑48 |
Analysis and inference within the molecular space: A visual approach using NAMS and multidimensional scalingAndre O. Falcao , University of Lisboa |
P‑50 |
Reaction Classification by Reaction VectorsGian Marco Ghiandoni, University of Sheffield |
P‑52 |
Tautomeric Equilibria: Modeling and Visualization.Marta Glavatskikh, University of Strasbourg |
P‑54 |
Artificial Intelligence in Medicinal Chemistry – Current Status at AstraZenecaThierry Kogej, AstraZeneca |
P‑56 |
Compact descriptor sets for automatic annotation of natural products in large databases by pairwise variable screeningMax Kretzschmar, Technische Universität Braunschweig |
P‑58 |
De novo drug-candidate molecule generation with generative adversarial networksXuhan Liu , Leiden University |
P‑60 |
The need for comprehensive reaction handling in SAVI and beyondMarc C. Nicklaus , National Cancer Institute, NIH |
P‑62 |
Flavours in AromaticityMartin Ott, Lhasa Limited |
P‑64 |
Smooth Molecular Surfaces with Joined Marching CubesThomas L. Sander, Idorsia Pharmaceutical Ltd. |
P‑66 |
Chemistry Identifier Mapping to Pathway Databases using Ontologies: Expanding metabolomics analysis in WikiPathways with ChEBIDenise Nicole Smaragda Michelle Slenter , Maastricht University |
P‑68 |
Finding answers from chemical space extremely fastAkos Tarcsay, ChemAxon |
P‑70 |
Structural Analysis of Protein Homomers – the Quest for Perfect SymmetryInbal Tuvi-Arad, The Open University of Israel |
P‑72 |
Wikidata and Scholia as a hub linking chemical knowledgeEgon Willighagen , Maastricht University |
P‑74 |
PSMILES – A particle-based Molecular Structure Representation for Mesoscopic SimulationAchim Zielesny, Westphalian University of Applied Sciences |
P‑76 |
A new, improved model to predict kinase inhibitionPieter FW Stouten, Galapagos NV |
P‑78 |